SKYX Platforms director receives stock, option grant
SKYX Platforms Corp. director Ridge Thomas J received equity compensation on March 31, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
SKYX Platforms Corp. director Ridge Thomas J received equity compensation on March 31, 2026. He was granted 5,000 shares of restricted common stock that vested immediately and 5,000 stock options with a $1.12 exercise price, vesting in twelve equal monthly installments beginning April 30, 2026. Following the grant, he directly owns 1,068,193 common shares, alongside multiple existing option awards with various exercise prices and expirations through 2030.
Insider Trade Summary
Grant/Award: 10,000 shares
Grant/Award
10 txns
Insider
Ridge Thomas J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 5,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock, no par value | 5,000 | $0.00 | $0.00 |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 550,000 contracts for 545,000 underlying shares (Direct);
Common Stock, no par value — 1,068,193 shares (Direct)
Footnotes (2)
- F1. Represents shares of restricted stock, which vested immediately upon grant and were granted pursuant to the non-employee director compensation program.
- F2. Options vest in twelve equal monthly installments, on the last day of each month, beginning on April 30, 2026. These options were granted pursuant to the non-employee director compensation program.
Key Figures
Restricted stock grant: 5,000 shares
New stock options granted: 5,000 options at $1.12
Option vesting schedule: 12 equal monthly installments
+4 more
7 metrics
Restricted stock grant
5,000 shares
Restricted common stock granted March 31, 2026; vested immediately
New stock options granted
5,000 options at $1.12
Exercise price $1.12; granted March 31, 2026
Option vesting schedule
12 equal monthly installments
Vesting on last day of each month starting April 30, 2026
Shares held after grant
1,068,193 shares
Total direct common stock holdings following restricted stock award
Longer-dated option expiry
March 31, 2031
Expiration date of newly granted 5,000 stock options at $1.12
Legacy option tranche
166,667 underlying shares at $3.00
Existing stock option position expiring April 19, 2027
High-strike option position
25,000 underlying shares at $12.00
Existing stock option position expiring December 31, 2026
Key Terms
restricted stock, non-employee director compensation program, Stock Option (right to buy), vest in twelve equal monthly installments, +1 more
5 terms
restricted stock financial
"Represents shares of restricted stock, which vested immediately upon grant"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
non-employee director compensation program financial
"were granted pursuant to the non-employee director compensation program"
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vest in twelve equal monthly installments financial
"Options vest in twelve equal monthly installments, on the last day of each month"
exercise price financial
"conversion_or_exercise_price": "1.1200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SKYX (SKYX) director Ridge Thomas J receive in this Form 4 filing?
He received equity compensation consisting of 5,000 restricted shares and 5,000 stock options. The restricted stock vested immediately, while the options were granted as part of the non-employee director compensation program with future vesting terms.
How do the new stock options for SKYX director Ridge Thomas J vest?
The 5,000 stock options vest in twelve equal monthly installments, on the last day of each month, starting April 30, 2026. This creates a gradual vesting schedule over one year under the non-employee director compensation program.
What is the exercise price and expiration date of the new SKYX stock options?
The newly granted 5,000 stock options have a $1.12 exercise price and expire on March 31, 2031. These options give the director the right to buy common stock at that price if they are vested and exercised before expiration.
What other stock options does SKYX director Ridge Thomas J hold according to this filing?
He holds multiple existing stock option awards with exercise prices ranging from $1.09 to $12.34. These options cover various underlying share amounts and have expiration dates between December 31, 2026 and March 27, 2030, providing long-dated potential equity exposure.
Is the SKYX Form 4 transaction a market buy or sell by the director?
No, the Form 4 reflects grant or award acquisitions, not open-market trades. The transactions are coded as awards (code A), representing compensation-related restricted stock and options, rather than discretionary buying or selling in the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates